Zoetis

Discussion in 'Valeant Pharmaceuticals' started by Anonymous, Nov 18, 2014 at 9:29 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Zoetis Inc., the animal-health products maker at the center of the latest round of pharmaceutical deal talk, said Tuesday that its board has approved a $500 million share-buyback program.

    The announcement comes a day after the company disclosed a deal to buy Abbott Laboratories’s ABT, -0.23% animal-health business for $255 million and about a week after the disclosure that activist investor William Ackman had taken a stake of about $2 billion in Zoetis.
     

  2. Anonymous

    Anonymous Guest

    And now also a seat on the board . Buckle up
     
  3. Anonymous

    Anonymous Guest

    Big changes in coming.
    3 executives "leaving"
    Couple others moving

    2500 to be laid off.
     
  4. Anonymous

    Anonymous Guest

    More like 1500 from what I hear...